PerkinElmer
check quantity

IVISense Acute Vascular 680 Fluorescent Probe (1 mg) (Genhance)

IVISense Acute Vascular (Genhance) fluorescent probes enable imaging and quantitation of acute vascular permeability increase, bladder clearance via intravital ureter imaging, or incorporation into liposomes for drug delivery monitoring.

For research use only. Not for use in diagnostic procedures.

Part Number
SKU Display Name
List Price
Your Price
Quantity
NEV10117
IVISense Acute Vascular 680 Fluorescent Probe (1 mg) (Genhance)
191.00 USD
 
more
NEV10130
IVISense Acute Vascular 680 Fluorescent Probe (5 mg) (Genhance)
728.00 USD
 
more
NEV10118
IVISense Acute Vascular 750 Fluorescent Probe (1 mg) (Genhance)
191.00 USD
 
more
NEV10177
IVISense Acute Vascular 750 Fluorescent Probe (5 mg) (Genhance)
728.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

IVISense Acute Vascular 680 fluorescent probe is small molecule near infrared fluorescent agent designed for in vivo preclinical intravenous (IV) administration. This probe, being of low molecular weight, rapidly leaks into regions of increased vascular permeability that can occur due to cancer or inflammation. In addition, its rapid clearance from the blood allows early imaging of the bladder or ureters for basic research or for surgical imaging approaches in small and large animals. The physical/chemical properties of this probe also makes it useful for encapsulation into nanoparticles or liposomes as a reporter system for drug delivery approaches.

This fluorescent probe is available in a 1 mg size.

Specifications

Fluorescent Agent Type Vascular
Optical Imaging Classification Fluorescence Imaging
Product Brand Name IVISense
Shipping Condition Ambient
Unit Size 1 mg
Wave Length 680 nm
Resources, Events & More
  • All

Ebook

In Vivo Imaging Solutions eBook

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And our hard-earned expertise makes us a trusted provider of pre-clinical imaging solutions— with more than 9,000 peer reviewed articles as proof.

PDF 4 MB

Flyer

Best Practices for Designing An Effective In Vivo Fluorescence Imaging Study

Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into disease processes and treatment effects. Designing an effective study from the beginning can help save time and resources.

Learn about several important best practices, from proper probe selection to study design to imaging technique tips and tricks needed to generate meaningful biological information from your in vivo fluorescence imaging studies.

PDF 507 KB

Guide

IVISense™ Fluorescent Probe Selector Guide for Oncology Research

The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.

This selector guide for IVISense fluorescent probes is a powerful tool to help advance your oncology research. By matching probe properties to specific biology and biomarker characteristics, you can better understand how imaging and quantification of early biological changes associated with disease development, therapeutic efficacy, and drug-induced tissue changes can be realized.

PDF 3 MB

Technical Note

Genhance 680 (1 mg) (Data Sheet)

Genhance™ 680 is the acid form of VivoTag® 680 that can be used as a control or a fluorescent in vivo blood pool imaging agent.,Upon dilution, a 1mg package of Genhance 680 provides sufficient reagents for imaging approximately 20 mice (weighing ~25 grams each) when using the recommended dose of 0.05mg/100 µL 1xPBS.

PDF 54 KB

White Paper

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick and efficient drug screening and evaluation. Read this White Paper to learn how preclinical in vivo imaging helps to ensure that smart choices are made by providing Go/No-Go decisions and de-risking drug candidates early on, significantly reducing time to the clinic and lowering costs all while maximizing biological understanding.

PDF 547 KB